Gregor Goldner

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. ncbi Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients
    Gregor Goldner
    Department of Radiation Oncology, Medical University of Vienna, Austria
    Radiother Oncol 103:223-7. 2012
  2. ncbi Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients
    G Goldner
    Department of Radiotherapy and Radiobiology, University Hospital of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Strahlenther Onkol 188:305-10. 2012
  3. ncbi Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Vienna, Austria
    Strahlenther Onkol 185:94-100. 2009
  4. ncbi Is the Roach formula predictive for biochemical outcome in prostate cancer patients with minimal residual disease undergoing local radiotherapy after radical prostatectomy?
    Gregor Goldner
    Department of Radiotherapy, University of Vienna Medical School, Austria
    Radiother Oncol 94:324-7. 2010
  5. ncbi Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Austria
    Strahlenther Onkol 187:202-5. 2011
  6. ncbi Prostate cancer radiotherapy in Austria: overview on number of patients, intention to treat, and treatment techniques based on data from 2007
    Gregor Goldner
    Department of Radiotherapy, University of Vienna Medical School, Vienna, Austria
    Strahlenther Onkol 187:279-83. 2011
  7. ncbi [Permanent interstitial brachytherapy (seeds) for patients with primary localized prostate cancer: analysis of 100 patients]
    Gregor Goldner
    Klinik fur Strahlentherapie, Medizinische Universität Wien, AKH, Wien, Austria
    Wien Klin Wochenschr 119:647-53. 2007
  8. ncbi Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Vienna, Austria
    Int J Radiat Oncol Biol Phys 67:78-83. 2007
  9. ncbi Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy)
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, University Hospital of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Strahlenther Onkol 182:537-42. 2006
  10. ncbi 3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Vienna, Austria
    Wien Klin Wochenschr 118:224-9. 2006

Detail Information

Publications24

  1. ncbi Comparison between external beam radiotherapy (70 Gy/74 Gy) and permanent interstitial brachytherapy in 890 intermediate risk prostate cancer patients
    Gregor Goldner
    Department of Radiation Oncology, Medical University of Vienna, Austria
    Radiother Oncol 103:223-7. 2012
    ....
  2. ncbi Comparison of seed brachytherapy or external beam radiotherapy (70 Gy or 74 Gy) in 919 low-risk prostate cancer patients
    G Goldner
    Department of Radiotherapy and Radiobiology, University Hospital of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Strahlenther Onkol 188:305-10. 2012
    ....
  3. ncbi Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Vienna, Austria
    Strahlenther Onkol 185:94-100. 2009
    ..Evaluation of late side effects and biochemical control (bNED) 5 years after three-dimensional radiotherapy with moderate, risk-adapted dose escalation...
  4. ncbi Is the Roach formula predictive for biochemical outcome in prostate cancer patients with minimal residual disease undergoing local radiotherapy after radical prostatectomy?
    Gregor Goldner
    Department of Radiotherapy, University of Vienna Medical School, Austria
    Radiother Oncol 94:324-7. 2010
    ....
  5. ncbi Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Austria
    Strahlenther Onkol 187:202-5. 2011
    ..To evaluate the time course of late rectal mucosal changes after prostate cancer radiotherapy (RT)...
  6. ncbi Prostate cancer radiotherapy in Austria: overview on number of patients, intention to treat, and treatment techniques based on data from 2007
    Gregor Goldner
    Department of Radiotherapy, University of Vienna Medical School, Vienna, Austria
    Strahlenther Onkol 187:279-83. 2011
    ..Aim of this analysis was to assess the current status of prostate cancer radiotherapy in Austria and compare these numbers to patients treated with surgery...
  7. ncbi [Permanent interstitial brachytherapy (seeds) for patients with primary localized prostate cancer: analysis of 100 patients]
    Gregor Goldner
    Klinik fur Strahlentherapie, Medizinische Universität Wien, AKH, Wien, Austria
    Wien Klin Wochenschr 119:647-53. 2007
    ....
  8. ncbi Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Vienna, Austria
    Int J Radiat Oncol Biol Phys 67:78-83. 2007
    ....
  9. ncbi Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy)
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, University Hospital of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
    Strahlenther Onkol 182:537-42. 2006
    ..Biochemical control (bNED), disease-specific survival (DSS), overall survival (OS), and late gastrointestinal (GI) and urogenital (UG) side effects (EORTC/RTOG) of patients with long-term follow-up were evaluated...
  10. ncbi 3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Vienna, Austria
    Wien Klin Wochenschr 118:224-9. 2006
    ..The purpose of the study was to investigate clinical feasibility and the influence of acute rectal side effects and pre-existing hemorrhoids on patients' acceptance of the rectal balloon catheter...
  11. ncbi 3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Vienna, Austria
    Radiother Oncol 78:36-40. 2006
    ..To identify endoscopic pathological findings prior to radiotherapy and a possible correlation with acute or chronic rectal side effects after three-dimensional conformal radiotherapy (3D-CRT) for prostate cancer...
  12. ncbi Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy
    Gregor Goldner
    Department of Radiotherapy, University of Vienna Medical School, Vienna, Austria
    Strahlenther Onkol 185:438-45. 2009
    ..To evaluate the clinical outcome in prostate cancer patients treated at one single institution by the implementation of moderate dose escalation...
  13. ncbi Late gastrointestinal and urogenital side-effects after radiotherapy--incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer
    Maximilian P Schmid
    University of Vienna Medical School, Austria
    Radiother Oncol 104:114-8. 2012
    ..The aim of this analysis was to describe additional relevant aspects of late side effects after prostate cancer radiotherapy...
  14. ncbi Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results
    Natascha Wachter-Gerstner
    Department of Radiotherapy, University of Vienna, Austria
    Strahlenther Onkol 178:542-7. 2002
    ..In this analysis, the impact of a short-term neoadjuvant hormonal treatment in combination with CRT to a moderate dose level of 66 Gy was examined...
  15. ncbi Critical discussion of different dose-volume parameters for rectum and urethra in prostate brachytherapy
    Christian Kirisits
    Department of Radiotherapy, Medical University of Vienna, Austria
    Brachytherapy 8:353-60. 2009
    ..To compare different dose-volume histogram (DVH) parameter concepts used for rectum and urethra...
  16. ncbi Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's report
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, General Hospital of Vienna, Medical School, University of Vienna, Austria
    Strahlenther Onkol 179:320-7. 2003
    ..Some studies could prove an over- or underestimation of side effects as assessed by the medical professionals. The aim of this study was to prospectively evaluate differences in side effects as described by the doctors and the patients...
  17. ncbi The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer
    Stefan Wachter
    Department of Radiotherapy and Radiobiology, Vienna General Hospital, University of Vienna Medical School, Vienna, Austria
    Int J Radiat Oncol Biol Phys 52:91-100. 2002
    ..In particular, influences on prostate motion, rectum filling variations, and dose-volume histograms (DVHs) of the rectum during a course of conformal radiotherapy were investigated...
  18. ncbi Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy
    Petra Georg
    Department of Radiotherapy, Medical University Vienna, Vienna, Austria
    Radiother Oncol 91:173-80. 2009
    ..Correlation of dosimetric parameters for MRI-based 3D treatment planning with rectoscopic findings and clinical rectal side effects...
  19. ncbi Interobserver comparison of CT and MRI-based prostate apex definition. Clinical relevance for conformal radiotherapy treatment planning
    Stefan Wachter
    Department of Radiotherapy and Radiobiology, University Hospital Vienna, Austria
    Strahlenther Onkol 178:263-8. 2002
    ..The aim of this study was to compare the localization of the prostatic apex in CT and axial MRI to the sagittal MRI in an interobserver analysis...
  20. ncbi Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study
    Carola Lütgendorf-Caucig
    Department of Radiotherapy, Medical University Vienna AKH Wien, Vienna, Austria
    Radiother Oncol 98:154-61. 2011
    ..Furthermore, CBCT contouring was benchmarked against other image modalities (CT, MR) and the influence of subjective image quality perception on inter-observer variability was assessed...
  21. ncbi Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance
    Jochen Reibenwein
    Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
    Prostate 67:427-32. 2007
    ..Our aim was to evaluate the feasibility of detection of hypermethylated genes in serum of prostate cancer patients and its correlation with clinicopathological parameters...
  22. ncbi Radiotherapy in lymph node-positive prostate cancer patients - a potential cure? Single institutional experience regarding outcome and side effects
    Gregor Goldner
    Department of Radiotherapy and Radiobiology, Medical School, University of Vienna, Vienna Austria
    Front Radiat Ther Oncol 41:68-76. 2008
    ..To conclude, advanced treatment techniques allowing dose escalation in the prostatic and pelvic region should be considered in selected lymph node-positive prostate cancer patients in order to further improve clinical outcome...
  23. ncbi Automatic patient alignment system using 3D ultrasound
    Marcus Kaar
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna A 1090, Austria
    Med Phys 40:041714. 2013
    ..15 ± 1.20 mm (ten patients).Conclusions: The authors developed a system for patient repositioning which works automatically without the necessity of user interaction with an accuracy which seems to be suitable for clinical application...
  24. ncbi Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk
    Johannes C A Dimopoulos
    Department of Radiotherapy and Radiobiology, Medical University of Vienna, Vienna, Austria
    Int J Radiat Oncol Biol Phys 64:1380-8. 2006
    ....